Gambaran Gejala Pasien Covid-19 dengan Komorbiditas Tuberkulosis di Rumah Sakit Al-Ihsan Kabupaten Bandung 2020-2022
Abstract
Abstract. Coronavirus Disease is an acute respiratory infectious disease. COVID-19 cases are rapidly increasing and spreading throughout Indonesia and have an impact on the number of deaths of the population.. The purpose of this study was to understand the differences in COVID-19 symptoms with Tuberculosis and non-Tuberculosis comorbidities at RSUD Al Ihsan Bandung. The purpose of this study was to understand the differences in COVID-19 symptoms with Tuberculosis and non-Tuberculosis comorbidities at RSUD Al Ihsan Bandung. The research method used in this study was descriptive using the Chi –Square statistical test to see the difference between COVID-19 and Tuberculosis and non-Tuberculosis comorbidities. The subjects of this study were patients confirmed with COVID-19 with Tuberculosis and Non-Tuberculosis comorbidities at RSUD Al Ihsan Bandung 2020-2022. Most tuberculosis patients were male 208 people (57.6%) and non-tuberculosis patients dominated by women 183 people (50.7%), The results showed that patients confirmed positive for COVID-19 with the most comorbid tuberculosis with mild symptoms especially shortness of breath were 202 people (55.9%) while 193 people (53.5%) non-tuberculosis comorbid patienst.It was concluded that there were significant differences between COVID-19 with pulmonary tuberculosis comorbidities and COVID-19 patients with non-tuberculosis comorbidities.
Abstrak. Coronavirus Disease adalah penyakit infeksi saluran pernapasan akut. Kasus COVID-19 dengan cepat meningkat dan menyebar ke seluruh Indonesia serta berdampak pada jumlah kematian populasi. Tujuan dilakukannya penelitian ini adalah untuk memahami perbedaan gejala COVID-19 dengan komorbiditas Tuberkulosis dan non Tuberkulosis di RSUD Al Ihsan Bandung. Metode penelitian yang digunakan dalam penelitian ini adalah deskriptif dengan menggunakan uji statistik Chi –Square untuk melihat perbedaan antara COVID-19 dengan komorbiditas Tuberkulosis dan non Tuberkulosis. Subjek penelitian ini adalah pasien yang terkonfirmasi COVID-19 dengan komorbiditas Tuberkulosis dan Non Tuberkulosis di RSUD Al Ihsan Bandung sebanyak 722 orang. Sebagian besar pasien Tuberkulosis berjenis kelamin laki-laki 208 orang (57,6%) dan pasien non Tuberkulosis didominasi perempuan 183 orang (50,7%), Hasil penelitian menunjukkan pasien terkonfirmasi positif COVID-19 dengan komorbid Tuberkulosis paling banyak yaitu pada gejala ringan terutama pada sesak nafas sebanyak 202 orang (55.9%) sedangkan pada pasien komorbid Non Tuberkulosis 193 orang (53.5%) Disimpulkan terdapat perbedaan yang signifikan antara COVID-19 dengan komorbiditas Tuberkulosis paru dan pasien COVID-19 dengan komorbiditas non Tuberkulosis.
References
Shereen MA, Khan S, Kazmi A, Bashir N, Siddique R. COVID-19 infection: Emergence, transmission, and characteristics of human coronaviruses. Journal of Advanced Research. doi:https://doi.org/10.1016/j.jare.2020.03.005
Southeast Asia Program. Southeast Asia Covid-19 Tracker. Johns Hopkins University and Southeast Asian Health Ministries. program/projects/southeastasia-covid-19-tracker. Published 2021. Accessed Juni 28, 2021.
Cucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta Biomed. 2020;91(1):157-160.
Kemkes P. Peta Sebaran COVID 19 INDONESIA. INFEKSI EMERGING, Media Informasi Resmi Terkini Penyakit Infeksi Emerging
Kementrian Kesehatan Republik Indonesia. Keputusan Menteri Kesehatan Republik Indonesia Nomor HK.01.07/MenKes/413/2020 Tentang Pedoman Pencegahan dan Pengendalian Corona Virus Disease 2019 (Covid-19). MenKes/413/2020. 2020;2019:207.
Satuan Tugas Penanganan COVID-19. Peta Sebaran Covid-19. 2021
Yuniarti E, Yuniarti E, Hermon D, et al. Mapping the High Risk Populations Against Coronavirus Disease 2019 in Padang West Sumatra Indonesia. Int Journals Sci High Technol. 2020;20(2):50-58. https://ijpsat.ijshtjournals.org/index.php/ijpsat/article/vie w/1754.
Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. doi:10.1016/S0140-6736(20)30183-5
Guan W-j, Liang W-h, Zhao Y et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J. 2020;74(10):640.
SeyedAlinaghi SA, Abbasian L, Solduzian M, et al. Predictors of the prolonged recovery period in COVID19 patients: a cross-sectional study. Eur J Med Res. 2021;26(1):1-10. 22.
Hu X, Xing Y, Jia J, et al. Factors associated with negative conversion of viral RNA in patients hospitalized with COVID-19. Sci ofthe Total Environ. 2020;(January).. Xue J, Zheng J, Shang X, et al. Risk factors for prolonged viral clearance in adult patients with COVID-19 in Beijing, China: A prospective observational study. Int Immunopharmacol. 2020;89(August):107031.
Samrah SM, Al-Mistarehi AH, Kewan T, et al. Viral clearance course of covid-19 outbreaks. J Multidiscip Healthc. 2021;14:555-565. 25. O’Brien J, Du KY, Peng C. Incidence, clinical features, and outcomes of COVID-19 in Canada: impact of sex and age. J Ovarian Res. 2020;13(1):1- 12.
Goodman KE, Magder LS, Baghdadi JD, et al. Impact of Sex and Metabolic Comorbidities on Coronavirus Disease 2019 (COVID-19) Mortality Risk Across Age Groups: 66 646 Inpatients Across 613 U.S. Hospitals. Clin Infect Dis. 2021;73(11):e4113-e4123
Liu, L. et al. (2020) ‘A preliminary study on serological assay for severe acute respiratory syndrome coronavirus 2 (SARS CoV 2) in 238 admi7ed hospital patients’, Microbes and Infection, 22(4–5), pp. 206–211. doi: 10.1016/j.micinf.2020.05.008.
Liu, Y. et al. (2020) ‘Neutrophil to lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID 19’, Journal of Infection. Elsevier Ltd, 81(1), pp. e6–e12. doi: 10.1016/j.jinf. 2020.04.002.
Mardani, R. et al. (2020) ‘Laboratory Parameters in Detection of COVID 19 Patients with Positive RT PCR; a Diagnostic Accuracy Study.’, Archives of Academic Emergency Medicine, 8(1), p. e43. doi: 10.22037/aaem.v8i1.632.
Patrucco, F. et al. (2020) ‘Coronavirus disease 2019 outbreak’, Panminerva Medica, 62(2), pp. 1–7. doi: 10.23736/ S0031 0808.20.03897 5. Perrier, A. et al. (2019) ‘The C terminal domain of the MERS coronavirus M protein contains a trans Golgi network localization signal’, Journal of BiologicalChemistry, 294(39), pp.
Sawicki, S. G. and Sawicki, D. L. (2005) ‘Coronaavirus transcription: a perpective’, Curr Top Microbiol Immunol, 287, pp. 31–55.
Shi, Y. et al. (2020) ‘COVID 19 infection: the perspectives on immune responses’, Cell Death & Differentiation, 27(5), pp. 1451–1454. doi: 10.1038/s41418 020 0530 3.
Bellan M, Patti G, Hayden E, Azzolina D, Pirisi M, Acquaviva A, dkk. Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients. Sci Rep [homepage pada Internet]. 2020;10(1):1–10.Alimohamadi Y, Tola HH, Abbasi-Ghahramanloo A, Janani M, Sepandi
Aditya Pradipta Lantik, Sadeli, and Purnomo, “Infeksi Helicobacter pylori pada Penderita Gastritis menjadi Faktor Risiko Anemia Defisiensi Besi,” Jurnal Riset Kedokteran, pp. 75–82, Dec. 2023, doi: 10.29313/jrk.v3i2.2880.
Aida Fitriyane Hamdani, Wida Purbaningsih, and Widhy Yudistira Nalapraya, “Karakteristik Demografi dan Klinikopatologi Pasien Kanker Paru di RSUD Al−Ihsan,” Jurnal Riset Kedokteran, pp. 97–102, Dec. 2023, doi: 10.29313/jrk.v3i2.2959.
V. Raveendran, “Perbandingan Karakteristik Penderita Otitis Media Akut di RSUP H. Adam Malik Medan pada Tahun 2014 dan 2015.” Skripsi, Universitas Sumatera Utara, Medan, 2017.
I. W. P. Mahardika, I. M. Sudipta, and D. W. S. Sutanegara, “Karakteristik Pasien Otitis Media Akut Di Rumah Sakit Umum Pusat Sanglah Denpasar Periode Januari-Desember Tahun 2014,” Jurnal Fakultas Kedokteran UNUD, vol. 8, no. 1, pp. 51–55, 2019.
S. N. Pratama, P. 1, H. Garna, and M. R. Akbar, “Hubungan Indeks Massa Tubuh, Kualitas Tidur, dan Tekanan Darah dengan Tingkat Stres Karyawan Pabrik PT Primastra Sandang Lestari Bandung Tahun 2022,” 2023. [Online]. Available: https://journal.sbpublisher.com/index.php/pharmacomedic
